Clinical Trial Update: Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis [NA]

View source ↗

Summary

A completed clinical trial evaluated prednisone in combination with Tripterygium wilfordii for adults with idiopathic focal segmental glomerulosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Drugs mentioned

• PREDNISONE (Prednisone)
• Tripterygium wilfordii (Tripterygium wilfordii)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Proteinuria, Focal Segmental Glomerulosclerosis | NA | Status: COMPLETED